Cardio Diagnostics Holdings, Inc.
NASDAQ: CDIOW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Meeshanthini V. Dogan
- Employees
- 13
- Headquarters
- Chicago, United States
- IPO year
- 2022
- Market cap
- $4.2M
- Website
- https://cardiodiagnosticsinc.com
Loading CDIOW…
Loading profile data…Frequently asked questions about CDIOW
What does Cardio Diagnostics Holdings, Inc. (CDIOW) do?
Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a thr...
Where does CDIOW trade?
Cardio Diagnostics Holdings, Inc. (CDIOW) trades on the NASDAQ Global Market.
What sector is CDIOW in?
Cardio Diagnostics Holdings, Inc. (CDIOW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cardio Diagnostics Holdings, Inc.?
Meeshanthini V. Dogan is the chief executive officer of Cardio Diagnostics Holdings, Inc. (CDIOW).
Where is Cardio Diagnostics Holdings, Inc. headquartered?
Cardio Diagnostics Holdings, Inc. is headquartered in United States.
Does CDIOW pay a dividend?
Cardio Diagnostics Holdings, Inc. (CDIOW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CDIOW go public?
Cardio Diagnostics Holdings, Inc. (CDIOW) completed its initial public offering in 2022.